Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials-Reference-Cited by-同舟云学术

Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials

Published:2021-10 Issue:10 Volume:21 Page:1345-1347
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Moran Ed,Cook Tim,Goodman Anna L,Gupta Ravindra K,Jolles Stephen,Menon David K,Roberts David J,Savic Sinisa,Shankar-Hari Manu,Brown Michael,Lowe David M

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference5 articles.

1. Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy;Helleberg;J Infect Dis,2020

2. Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19;Hueso;Blood,2020

3. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial;Lancet,2021

4. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial;Horby;medRxiv,2021

5. SARS-CoV-2 evolution during treatment of chronic infection;Kemp;Nature,2021

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug;Cell Death & Disease;2024-06-28

2. Persistence of SARS‐CoV‐2 infection and viral intra‐ and inter‐host evolution in COVID‐19 hospitalized patients;Journal of Medical Virology;2024-05-28

3. Case 40-2023: A 70-Year-Old Woman with Cough and Shortness of Breath;New England Journal of Medicine;2023-12-28

4. Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities;Advances in Therapy;2023-11-27

5. SARS-CoV-2 inhibition and specific targeting of infected cells by VSV particles carrying the ACE2 receptor;Signal Transduction and Targeted Therapy;2023-05-21